2 unknown, 1 recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 2, Recruiting 1 |
| Phase 2 | 1 | Unknown 1 |
Follow PD-1: new trials by email Literature Review of PD-1 trials Research Report on PD-1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer transfusion of 5×10^8 PD-1 knockout TILs per kg body weight, transfusion of 1×10^9 PD-1 edited TILs per kg body weight, transfusion of 2×10^9 PD-1 edited TILs per kg body weight - Colorectal Cancer (CRC), Tumor Infiltrating Lymphocytes | Phase 1 | Recruiting | Ruijin Hospital | 29 | 2024-12-31 | 2025-06-24 |
| Total Neoadjuvant Treatment Plus PD-1 in Mid-Low Locally Advanced Rectal Cancer Sintilimab - Tislelizumab, Locally Advanced Rectal Cancer | Phase 1 | Unknown | The First Hospital of Jilin University | 46 | 2021-06-01 | 2023-11-18 |
| Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ PD-1 - PD-1, Chemoradiotherapy | Phase 1 / Phase 2 | Unknown | Peking University | 45 | 2019-08-26 | 2019-08-20 |
Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Rectal Diseases (1)
sintilimab (1) · toripalimab (1)
Peking University (1) · Ruijin Hospital (1) · The First Hospital of Jilin University (1)
China (2)
Yongheng Li, MD (1) · Ziyu Li, MD (1)